BeOne Medicines (ONC) Current Leases: 2019-2024
Historic Current Leases for BeOne Medicines (ONC) over the last 6 years, with Dec 2024 value amounting to $17.6 million.
- BeOne Medicines' Current Leases fell 11.15% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 11.15%. This contributed to the annual value of $17.6 million for FY2024, which is 19.93% down from last year.
- Per BeOne Medicines' latest filing, its Current Leases stood at $17.6 million for FY2024, which was down 19.93% from $21.9 million recorded in FY2023.
- In the past 5 years, BeOne Medicines' Current Leases ranged from a high of $24.0 million in FY2022 and a low of $13.9 million during FY2020.
- In the last 3 years, BeOne Medicines' Current Leases had a median value of $21.9 million in 2023 and averaged $21.2 million.
- Per our database at Business Quant, BeOne Medicines' Current Leases skyrocketed by 57.79% in 2021 and then decreased by 19.93% in 2024.
- Yearly analysis of 5 years shows BeOne Medicines' Current Leases stood at $13.9 million in 2020, then spiked by 57.79% to $21.9 million in 2021, then increased by 9.65% to $24.0 million in 2022, then decreased by 8.70% to $21.9 million in 2023, then decreased by 19.93% to $17.6 million in 2024.